Hepatocyte growth factor induces Wnt-independent nuclear translocation of β-catenin after Met-β-catenin dissociation in hepatocytes

Cancer Research

Volumn 62, Issue 7, 2002, Pages 2064-2071

  Monga, Satdarshan P S ^a   Mars, Wendy M ^a   Pediaditakis, Peter ^a   Bell, Aaron ^a   Mulé, Karen ^a   Bowen, William C ^a   Wang, Xue ^a   Zarnegar, Reza ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GENE PRODUCT; MET BETA CATENIN; NUCLEAR PROTEIN; PROTEIN SUBUNIT; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; COMPLEX FORMATION; DISSOCIATION; DOSE RESPONSE; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE TARGETING; GENE TRANSLOCATION; LIVER CELL; LIVER CELL CULTURE; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CELL NUCLEUS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; MALE; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, INBRED F344; SERINE; SIGNAL TRANSDUCTION; THREONINE; TRANS-ACTIVATORS; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 0036531819     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Epithelial mesenchymal interactions in cancer and development
2. Linking colorectal cancer to Wnt signaling
3. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
4. Differential mechanisms of LEF/TCF family-dependent transcriptional activation by β-catenin and plakoglobin
5. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin
6. Changes in WNT/β-catenin pathway during regulated growth in rat liver regeneration
7. Control of β-catenin stability: Reconstitution of the cytoplasmic steps of the Wnt pathway in Xenopus egg extracts
8. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins
9. WNT-1 and HGF regulate GSK3 β activity and β-catenin signaling in mammary epithelial cells
10. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
11. Wnt signaling to β-catenin involves two interactive components. Glycogen synthase kinase-3β inhibition and activation of protein kinase C
12. Patterning and nuclear β-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation
13. Activation of β-catenin in epithelial and mesenchymal hepatoblastomas
14. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation
15. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
16. HGF/SF modifies the interaction between its receptor c-Met and the E-cadherin/catenin complex in prostate cancer cells
17. Distinct β-catenins mediate adhesion and signalling functions in C. elegans
18. Regulation of HGF and HGFR gene expression
19. Expression of HGF-SF in normal and malignant human tissues
20. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice
21. The presence of hepatocyte growth factor in the developing rat
22. c-met tyrosine kinase receptor expression is associated with abnormal β-catenin expression and favourable prognostic factors in invasive breast carcinoma
23. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor
24. An epithelial scatter factor released by embryo fibroblasts
25. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
26. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells
27. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
28. Hepatocyte growth factor/scatter factor disrupts epithelial tumour cell-cell adhesion: Involvement of β-catenin
29. Distinct morphological and mito-inhibitory effects induced by TGF-β1 HGF and EGF on mouse, rat and human hepatocytes
30. Matrix induced re-differentiation of cultured rat hepatocytes and changes of CCAAT/enhancer binding proteins
31. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF α in a chemically defined (HGM) medium
32. Differential detergent fractionation of isolated hepatocytes: Biochemical, immunochemical and two-dimensional gel electrophoresis characterization of cytoskeletal and noncytoskeletal compartments
33. A mechanism of cell survival: Sequestration of Fas by the HGF receptor Met
34. Wnt/β-catenin signaling induces the expression and activity of βTrCP ubiquitin ligase receptor
35. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway
36. Nuclear endpoint of Wnt signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1
37. Nuclear accumulation of β-catenin is a common and early event during neoplastic progression of Barrett esophagus
38. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin
39. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
40. Induction of tyrosine phosphorylation and association of β-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence
41. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells - Regulation by Rho, Rac and Rab small G proteins
42. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma
43. Hepatocyte growth factor for liver disease
44. Serum hepatocyte growth factor levels in liver diseases: Clinical implications
45. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat